HIV prevention and treatment fields join forces

EBioMedicine

Volumn 1, Issue 1, 2014, Pages 4-5

  Deeksa, Steven G ^a   Siliciano, Robert ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS; DISEASE TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MEDICAL RESEARCH; NONHUMAN; POST EXPOSURE PROPHYLAXIS; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL;

EID: 84921948213     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2014.10.009     Document Type: Note

References (9)

1. Barouch, D.H., Deeks, S.G., 2014. Immunologic strategies for HIV-1 remission and eradication. Science 345, 169-174.
2. Barouch, D.H., Whitney, J.B., Moldt, B., Klein, F., Oliveira, T.Y., Liu, J., et al., 2013. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIVinfected rhesus monkeys. Nature 503, 224-228.
3. Cohen, M.S., Chen, Y.Q., McCauley, M., Gamble, T., Hosseinipour, M.C., Kumarasamy, N., et al., 2011. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365, 493-505.
4. Grant, R.M., Lama, J.R., Anderson, P.L., McMahan, V., Liu, A.Y., Vargas, L., et al., 2010. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363, 2587-2599.
5. Hansen, S.G., MP Jr., Ventura, A.B., Hughes, C.M., Gilbride, R.M., Ford, J.C., et al., 2013. Immune clearance of highly pathogenic SIV infection. Nature 502, 100-104.
6. Haynes, B.F., Gilbert, P.B., McElrath, M.J., Zolla-Pazner, S., Tomaras, G.D., Alam, S.M., et al., 2012. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275-1286.
7. Persaud, D., Gay, H., Ziemniak, C., Chen, Y.H., Piatak Jr., M., Chun, T.W., et al., 2013. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N. Engl. J. Med. 369, 1828-1835.
8. Shan, L., Deng, K., Shroff, N.S., Durand, C.M., Rabi, S.A., Yang, H.C., et al., 2012. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36, 491-501.
9. Siliciano, J.D., Kajdas, J., Finzi, D., Quinn, T.C., Chadwick, K., Margolick, J.B., et al., 2003. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9, 727-728.